We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+9.4%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$45.6B
AUM Growth
+$1.73B
Cap. Flow
-$1.83B
Cap. Flow %
-4.01%
Top 10 Hldgs %
6.56%
Holding
3,433
New
444
Increased
1,183
Reduced
1,306
Closed
348

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$254M
2
BAC icon
Bank of America
BAC
+$228M
3
KLAC icon
KLA
KLAC
+$205M
4
TSM icon
TSMC
TSM
+$191M
5
CVS icon
CVS Health
CVS
+$182M

Sector Composition

Rank Sector Weight
1 Technology 17.63%
2 Healthcare 13.66%
3 Financials 12.91%
4 Industrials 10.81%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNAI
3001
Lunai Bioworks
LNAI
$10.9M
$10.9K ﹤0.01%
+281
New +$19.5K
BNGO icon
3002
Bionano Genomics
BNGO
$13.3M
$10.7K ﹤0.01%
+395
New +$12.3K
ITP icon
3003
IT Tech Packaging
ITP
$2.99M
$10.5K ﹤0.01%
40,180
+10
+0% +$2
VEV
3004
DELISTED
Vicinity Motor Corp. Common Stock
VEV
$10.4K ﹤0.01%
+76,707
New +$20.6K
VINC
3005
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$10.2K ﹤0.01%
711
-140
-16% -$1.92K
AGPU
3006
Axe Compute Inc
AGPU
$96.6M
$9.9K ﹤0.01%
+837
New +$12.4K
AMBP.WS
3007
DELISTED
Ardagh Metal Packaging Warrants
AMBP.WS
$8.63K ﹤0.01%
298,700
XLO icon
3008
Xilio Therapeutics
XLO
$60.3M
$8.18K ﹤0.01%
+742
New +$9.11K
AKTS
3009
DELISTED
Akoustis Technologies Inc
AKTS
$7.97K ﹤0.01%
89,088
-137,141
-61% -$13.2K
CBIO
3010
Crescent Biopharma
CBIO
$626M
$7.54K ﹤0.01%
+446
New +$9.36K
AEMD icon
3011
Aethlon Medical
AEMD
$1.66M
$7.2K ﹤0.01%
+39
New +$6.2K
NXL icon
3012
Nexalin Technology
NXL
$7.77M
$7.13K ﹤0.01%
+10,658
New +$11K
SRTAW
3013
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$7.09K ﹤0.01%
37,300
ADVWW
3014
DELISTED
Advantage Solutions Warrant
ADVWW
$6.85K ﹤0.01%
218,099
SES icon
3015
SES AI
SES
$208M
$6.79K ﹤0.01%
+10,611
New +$11.1K
ENVB icon
3016
Enveric Biosciences
ENVB
$6.24M
$6.34K ﹤0.01%
+74
New +$6.81K
CTNT icon
3017
Cheetah Net Supply Chain Service
CTNT
$6.1M
$6.27K ﹤0.01%
+9
New +$8.71K
CGTX icon
3018
Cognition Therapeutics
CGTX
$96.7M
$5.33K ﹤0.01%
+11,370
New +$11.7K
VGASW icon
3019
Verde Clean Fuels Warrant
VGASW
$728K
$5.08K ﹤0.01%
24,212
STI icon
3020
Solidion Technology
STI
$61.3M
$4.57K ﹤0.01%
+248
New +$4.79K
GGROW
3021
Gogoro Inc Warrant
GGROW
$187K
$4.18K ﹤0.01%
104,838
ECXWW
3022
ECARX Holdings Warrants
ECXWW
$3.51K ﹤0.01%
164,699
ADTX
3023
DELISTED
ADITXT INC
ADTX
0
SISI
3024
DELISTED
Shineco
SISI
$3.41K ﹤0.01%
+12
New +$11.8K
KULR icon
3025
KULR Technology Group
KULR
$135M
$3.4K ﹤0.01%
1,494
-28
-2% -$63

Similar funds

Two Sigma Investments's Q3 2024 Portfolio in Review

As of Q3 2024, Two Sigma Investments held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

Two Sigma Investments withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Two Sigma Investments opened a new position in Bank of America worth $226M.

  • Two Sigma Investments's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
  • Two Sigma Investments added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
  • Two Sigma Investments's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
  • Two Sigma Investments fully exited Intel in Q3 2024, selling an estimated $161M.
  • Two Sigma Investments's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
  • Two Sigma Investments opened 444 new positions and closed 348 in Q3 2024.
  • Two Sigma Investments's portfolio value rose 3.9% quarter-over-quarter to $45.6B.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.